"Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury." Regulatory Peptides
Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
KK received lecture honoraria from Sumitomo Pharma, Astra Zeneca, Otsuka, Taisho Pharma, Tanabe-Mitsubishi, Eli Lilly, Boehringer-Ingelheim, Novo Nordisk, Bayer, Novartis, and Kowa
Use only as prescribed
The New York Times reports some patients are finding a way around both of these concerns by experimenting with microdosing the drugs
It may enhance energy levels, support metabolism, and improve overall wellness